Title: Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay.
Journal: Annals of the rheumatic diseases 20120301
Title: The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro.
Journal: Molecular medicine (Cambridge, Mass.) 20110101
Title: Effects of the histone deacetylase inhibitor ITF2357 in autoinflammatory syndromes.
Journal: Molecular medicine (Cambridge, Mass.) 20110101
Title: ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study.
Journal: Anticancer research 20101101
Title: The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro.
Journal: Journal of acquired immune deficiency syndromes (1999) 20100501
Title: Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.
Journal: The Journal of clinical investigation 20080701
Title: Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice.
Journal: Gut 20080501
Title: Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects.
Journal: International journal of oncology 20080101
Title: HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.
Journal: Hepatology (Baltimore, Md.) 20060301
Title: Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.
Journal: Journal of hepatology 20050201
Title: Li S, et al. Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo. J Biol Chem. 2015 Jan 23;290(4):2368-78.
Title: Wang YG, et al. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation. World J Gastroenterol. 2015 Jul 21;21(27):8326-39.
Title: Leoni F, et al. The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med. 2005 Jan-Dec;11(1-12):1-15.
